These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

189 related articles for article (PubMed ID: 28497130)

  • 1. Not all that glitters is gold: A guide to critical appraisal of animal drug trials in epilepsy.
    Galanopoulou AS; Mowrey WB
    Epilepsia Open; 2016 Dec; 1(3-4):86-101. PubMed ID: 28497130
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Identification of new epilepsy treatments: issues in preclinical methodology.
    Galanopoulou AS; Buckmaster PS; Staley KJ; Moshé SL; Perucca E; Engel J; Löscher W; Noebels JL; Pitkänen A; Stables J; White HS; O'Brien TJ; Simonato M;
    Epilepsia; 2012 Mar; 53(3):571-82. PubMed ID: 22292566
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Epilepsy therapy development: technical and methodologic issues in studies with animal models.
    Galanopoulou AS; Kokaia M; Loeb JA; Nehlig A; Pitkänen A; Rogawski MA; Staley KJ; Whittemore VH; Dudek FE
    Epilepsia; 2013 Aug; 54 Suppl 4(0 4):13-23. PubMed ID: 23909850
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Fit for purpose application of currently existing animal models in the discovery of novel epilepsy therapies.
    Löscher W
    Epilepsy Res; 2016 Oct; 126():157-84. PubMed ID: 27505294
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Development of new treatment approaches for epilepsy: unmet needs and opportunities.
    French JA; White HS; Klitgaard H; Holmes GL; Privitera MD; Cole AJ; Quay E; Wiebe S; Schmidt D; Porter RJ; Arzimanoglou A; Trinka E; Perucca E
    Epilepsia; 2013 Aug; 54 Suppl 4():3-12. PubMed ID: 23909849
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Antiepileptogenesis and disease modification: Progress, challenges, and the path forward-Report of the Preclinical Working Group of the 2018 NINDS-sponsored antiepileptogenesis and disease modification workshop.
    Galanopoulou AS; Löscher W; Lubbers L; O'Brien TJ; Staley K; Vezzani A; D'Ambrosio R; White HS; Sontheimer H; Wolf JA; Twyman R; Whittemore V; Wilcox KS; Klein B
    Epilepsia Open; 2021 Jun; 6(2):276-296. PubMed ID: 34033232
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Optimized methods for epilepsy therapy development using an etiologically realistic model of focal epilepsy in the rat.
    Eastman CL; Fender JS; Temkin NR; D'Ambrosio R
    Exp Neurol; 2015 Feb; 264():150-62. PubMed ID: 25523813
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Challenges and directions in epilepsy diagnostics and therapeutics: Proceedings of the 17th Epilepsy Therapies and Diagnostics Development conference.
    Terman SW; Kirkpatrick L; Kerr WT; Akiyama LF; Baajour W; Atilgan D; Dorotan MKC; Choi HW; French JA
    Epilepsia; 2024 Apr; 65(4):846-860. PubMed ID: 38135921
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Discovery and validation of blood microRNAs as molecular biomarkers of epilepsy: Ways to close current knowledge gaps.
    Enright N; Simonato M; Henshall DC
    Epilepsia Open; 2018 Dec; 3(4):427-436. PubMed ID: 30525113
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inflammation and Epilepsy: Preclinical Findings and Potential Clinical Translation.
    Terrone G; Salamone A; Vezzani A
    Curr Pharm Des; 2017; 23(37):5569-5576. PubMed ID: 28950818
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preclinical Animal Models for Dravet Syndrome: Seizure Phenotypes, Comorbidities and Drug Screening.
    Griffin A; Hamling KR; Hong S; Anvar M; Lee LP; Baraban SC
    Front Pharmacol; 2018; 9():573. PubMed ID: 29915537
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Animal Models of Seizures and Epilepsy: Past, Present, and Future Role for the Discovery of Antiseizure Drugs.
    Löscher W
    Neurochem Res; 2017 Jul; 42(7):1873-1888. PubMed ID: 28290134
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The challenge and promise of anti-epileptic therapy development in animal models.
    Simonato M; Brooks-Kayal AR; Engel J; Galanopoulou AS; Jensen FE; Moshé SL; O'Brien TJ; Pitkanen A; Wilcox KS; French JA
    Lancet Neurol; 2014 Sep; 13(9):949-60. PubMed ID: 25127174
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Common data elements for preclinical epilepsy research: Standards for data collection and reporting. A TASK3 report of the AES/ILAE Translational Task Force of the ILAE.
    Harte-Hargrove LC; French JA; Pitkänen A; Galanopoulou AS; Whittemore V; Scharfman HE
    Epilepsia; 2017 Nov; 58 Suppl 4(Suppl 4):78-86. PubMed ID: 29105074
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Animal models of epilepsy for the development of antiepileptogenic and disease-modifying drugs. A comparison of the pharmacology of kindling and post-status epilepticus models of temporal lobe epilepsy.
    Löscher W
    Epilepsy Res; 2002 Jun; 50(1-2):105-23. PubMed ID: 12151122
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Issues for new antiepilepsy drug development.
    Simonato M; French JA; Galanopoulou AS; O'Brien TJ
    Curr Opin Neurol; 2013 Apr; 26(2):195-200. PubMed ID: 23406913
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Critical review of current animal models of seizures and epilepsy used in the discovery and development of new antiepileptic drugs.
    Löscher W
    Seizure; 2011 Jun; 20(5):359-68. PubMed ID: 21292505
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The clinical effectiveness and cost-effectiveness of technologies used to visualise the seizure focus in people with refractory epilepsy being considered for surgery: a systematic review and decision-analytical model.
    Burch J; Hinde S; Palmer S; Beyer F; Minton J; Marson A; Wieshmann U; Woolacott N; Soares M
    Health Technol Assess; 2012; 16(34):1-157, iii-iv. PubMed ID: 22985954
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Felbamate as an add-on therapy for refractory partial epilepsy.
    Shi LL; Dong J; Ni H; Geng J; Wu T
    Cochrane Database Syst Rev; 2017 Jul; 7(7):CD008295. PubMed ID: 28718506
    [TBL] [Abstract][Full Text] [Related]  

  • 20.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.